BLEG (Branded Legacy) Sloan Ratio %: 0.00% (As of Dec. 2021)


What is Branded Legacy Sloan Ratio %?

Branded Legacy BLEG Sloan Ratio % is 0.00% as of Dec. 2021.

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Branded Legacy's Sloan Ratio for the quarter that ended in Dec. 2021 was 0.00%.

As of Dec. 2021, Branded Legacy has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Branded Legacy  (OTCPK:BLEG) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2021, Branded Legacy has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Branded Legacy Sloan Ratio % Related Terms


Branded Legacy Sloan Ratio % Historical Data

* Premium members only.

The historical data trend for Branded Legacy's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Branded Legacy Sloan Ratio % Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Sloan Ratio %
Get a 7-Day Free Trial 0.00 225.93 66.98 -22.67 -29.17

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BLEG vs UPDC, RIBT, GDMK: Sloan Ratio % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Branded Legacy's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Branded Legacy Sloan Ratio % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Branded Legacy's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Branded Legacy's Sloan Ratio % falls into.



Branded Legacy Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Branded Legacy's Sloan Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2021 )-Cash Flow from Operations (A: Dec. 2021 )
-Cash Flow from Investing (A: Dec. 2021 ))/Total Assets (A: Dec. 2021 )
=(-0.314--0.27
--0.009)/0.12
=-29.17%

Branded Legacy's Sloan Ratio for the quarter that ended in Dec. 2021 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2021 )
=(-0.314--0.271
-0)/0.12
=-35.83%

Branded Legacy's Net Income for the trailing twelve months (TTM) ended in Dec. 2021 was -0.052 (Mar. 2021 ) + -0.107 (Jun. 2021 ) + -0.036 (Sep. 2021 ) + -0.119 (Dec. 2021 ) = $-0.31 Mil.
Branded Legacy's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2021 was -0.038 (Mar. 2021 ) + -0.094 (Jun. 2021 ) + -0.04 (Sep. 2021 ) + -0.099 (Dec. 2021 ) = $-0.27 Mil.
Branded Legacy's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2021 was 0 (Mar. 2021 ) + 0 (Jun. 2021 ) + 0 (Sep. 2021 ) + 0 (Dec. 2021 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Sloan Ratio % →
What does a Sloan Ratio % of 0.00% mean?
Branded Legacy (BLEG) has a Sloan Ratio % of 0.00% as of Dec. 2021. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Branded Legacy and its competitors.
Is Branded Legacy's Sloan Ratio % too high?
Branded Legacy's current Sloan Ratio % is 0.00%.
How does Branded Legacy's Sloan Ratio % compare to UPDC and RIBT?
Branded Legacy's Sloan Ratio % of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Drug Manufacturers company?
A good Sloan Ratio % depends on the Drug Manufacturers industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Branded Legacy and its competitors. Branded Legacy's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEG) has a current Sloan Ratio % of 0.00%. The current Sloan Ratio % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Branded Legacy (BLEG), the current Sloan Ratio % is 0.00% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Branded Legacy Business Description

Address 751 North Drive, Suite 9, Melbourne, FL, USA, 32934
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.